FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-028 | 71591-028-01 | Doxycycline Hyclate | 25 mg | 2019-1 | valid | 2026-11-14 | ||
| "Atlas Pharmaceuticals, LLC(057234359)" | 71591-029 | 71591-029-01 | Enrofloxacin | 204 mg | 2019-1 | valid | 2026-11-14 | ||
| "Auro Pharmacies, Inc(080357512)" | Amino Acids | 8.5 g/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Glutathione | 200 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Glutathione | 200 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Magnesium Chloride | 300 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Methionine; Choline Chloride; Inositol | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Methylcobalamin | 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Methylcobalamin | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Biotin | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Pyridoxal Phosphate | 10 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Taurine | 50 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Calcium Chloride | 100 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Calcium Gluconate; Calcium Saccharate | 47.5 mg/1 mL; 2.5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Auro Pharmacies, Inc(080357512)" | Dexpanthenol | 2019-1 | source_no_ndc | 2026-11-14 | |||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Glycopyrrolate | .2 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Heparin Sodium | 5000 U/500 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Heparin Sodium | 10000 U/1000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Heparin Sodium | 4000 U/1000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Heparin Sodium | 5000 U/1000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Heparin Sodium | 12500 U/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Atropine Sulfate | .4 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Iohexol | 300 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Labetalol Hydrochloride | 5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Magnesium Sulfate Heptahydrate | 1 g/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Magnesium Sulfate Heptahydrate | 2 g/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Magnesium Sulfate Heptahydrate | 2 g/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Magnesium Sulfate Heptahydrate | 10 g/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Methotrexate Sodium | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Methotrexate Sodium | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Methotrexate Sodium | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Moxifloxacin Hydrochloride | 1.5 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Norepinephrine Bitartrate | 16 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Oxytocin | 20 U/500 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Oxytocin | 20 U/1000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Oxytocin | 30 U/500 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Phenylephrine Hydrochloride | 100 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Phenylephrine Hydrochloride | 25 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Phenylephrine Hydrochloride | 40 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Phenylephrine Hydrochloride | 20 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "Avella of Deer Valley, Inc. #38(080263836)" | Bevacizumab | 25 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 |